HilleVax, Inc. (HLVX) Operating Income (Loss) USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
HilleVax, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2024.
  • HilleVax, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$49.8 M, a 72% decline year-over-year.
  • HilleVax, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$154 M, a 86.3% decline year-over-year.
  • HilleVax, Inc. annual Operating Income (Loss) for 2023 was -$133 M, a 105% decline from 2022.
  • HilleVax, Inc. annual Operating Income (Loss) for 2022 was -$65.1 M, a 21.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$154 M -$49.8 M -$20.8 M -72% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$133 M -$40.3 M -$17.2 M -74.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 -$116 M -$33.9 M -$16 M -89.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$100 M -$30.2 M -$17.4 M -136% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$82.8 M -$29 M -$17.6 M -156% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$65.1 M -$23.1 M -$12 M -109% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 -$53.1 M -$17.9 M +$21.8 M +54.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$74.9 M -$12.8 M -$11.6 M -956% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$63.3 M -$11.3 M -$9.85 M -672% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$53.4 M -$11.1 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 -$39.7 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$1.21 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$1.47 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-06-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.